Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies Read more
Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies Read more
Global Leaders in Cell Therapy for Autoimmune Diseases Converge at the 2nd Cell Therapy for Autoimmune Disease Summit Read more
Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada Read more
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers Read more
Amneal and Shilpa Announce FDA Approval of BORUZU, the First Ready-to-Use Version of Bortezomib for subcutaneous administration Read more
NImmune Biopharma Announces R&D Collaboration with BioTherapeutics, Inc. to Advance the Next Wave of Inflammation and Immunology Precision Medicines Read more
Abdera Therapeutics Announces FDA Orphan Drug Designation for ABD-147 for the Treatment of Neuroendocrine Carcinoma Read more